Liver elastography-based risk score for predicting hepatocellular carcinoma risk
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djae304 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Chan Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Elasticity Imaging Techniques, Hepatitis B, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Liver stiffness measurement (LSM) via vibration-controlled transient elastography accurately assesses fibrosis. We aimed to develop a universal risk score for predicting hepatocellular carcinoma (HCC) development in patients with chronic hepatitis.
Methods
We systematically selected predictors and developed the risk prediction model (HCC-LSM) in the hepatitis B virus (HBV) training cohort (n = 2251, median follow-up of 3.2 years). The HCC-LSM model was validated in an independent HBV validation cohort (n = 1191, median follow-up of 5.7 years) and a non-viral chronic liver disease (CLD) extrapolation cohort (n = 1189, median follow-up of 3.3 years). An HCC risk score was then constructed based on a nomogram. An online risk evaluation tool Liver Elastography-Based Hepatocellular Carcinoma Risk Score (LEBER) was developed using ChatGPT4.0.
Results
Eight routinely available predictors were identified, with LSM levels showing a significant dose-response relationship with HCC incidence (P < .001 by log-rank test). The HCC-LSM model exhibited excellent predictive performance in the HBV training cohort (C-index = 0.866) and the HBV validation cohort (C-index = 0.852), with good performance in the extrapolation CLD cohort (C-index = 0.769). The model demonstrated significantly superior discrimination compared to 6 previous models across the 3 cohorts. Cut-off values of 87.2 and 121.1 for the HCC-LSM score categorized participants into low-, medium-, and high-risk groups. An online public risk evaluation tool (LEBER; http://ccra.njmu.edu.cn/LEBER669.html) was developed to facilitate the use of HCC-LSM.
Conclusion
The accessible, reliable risk score based on LSM accurately predicted HCC development in patients with chronic hepatitis, providing an effective risk assessment tool for HCC surveillance strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Health Management Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
- Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, P. R. China.
- Department of Liver Diseases, The Third People's Hospital of Changzhou, Changzhou 213000, Jiangsu, China.
- Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
ORCID-Profile: Chunyan Ye, Xiao Wang, Chengxiao Yu, Jing Lu, Ci Song
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tian, C., Ye, C., Guo, H., Lu, K., Yang, J., Wang, X., Ge, X., Yu, C., Lu, J., Jiang, L., Zhang, Q., & Song, C. (2025). Liver elastography-based risk score for predicting hepatocellular carcinoma risk. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae304
Vancouver
Tian C, Ye C, Guo H, Lu K, Yang J, Wang X, et al. Liver elastography-based risk score for predicting hepatocellular carcinoma risk. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae304
BibTeX
@article{Tian2025,
author = {Tian, Chan and Ye, Chunyan and Guo, Haiyan and Lu, Kun and Yang, Juan and Wang, Xiao and Ge, Xinyuan and Yu, Chengxiao and Lu, Jing and Jiang, Longfeng and Zhang, Qun and Song, Ci},
title = {Liver elastography-based risk score for predicting hepatocellular carcinoma risk},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djae304}
}
EUVIMED